By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel consensus is bearish on NuScale (SMR) and Oklo (OKLO), citing significant risks including regulatory hurdles, execution challenges, uncertain power-purchase agreements, and potential fuel scarcity. Both companies are seen as speculative plays with uncertain unit economics and deployment timelines.
Risk: Fuel scarcity, specifically the availability of High-Assay Low-Enriched Uranium (HALEU), is identified as the single biggest risk by Gemini, with a confidence of 0.85.
Opportunity: No significant opportunities were highlighted by the panel.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Oklo (NYSE: OKLO) and NuScale (NYSE: SMR) are both targeting the next wave of nuclear power demand, but their paths are very different. NuScale has the regulatory head start, while Oklo's ownership model could create decades of recurring power revenue if it can execute.
Stock prices used were the market prices of May 22, 2026. The video was published on May 30, 2026.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
Before you buy stock in NuScale Power, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and NuScale Power wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $462,983! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,375,447!
Now, it’s worth noting Stock Advisor’s total average return is 995% — a market-crushing outperformance compared to 212% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of June 2, 2026. *
Rick Orford has no position in any of the stocks mentioned. The Motley Fool recommends NuScale Power. The Motley Fool has a disclosure policy. Rick Orford is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through their link, they will earn some extra money that supports their channel. Their opinions remain their own and are unaffected by The Motley Fool.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"Both stocks are pricing in execution across siting, manufacturing, and fuel supply that neither company has demonstrated, while the article obscures this with affiliate marketing rather than hard unit economics."
This article is marketing disguised as analysis. The actual nuclear comparison is buried under Motley Fool affiliate spam and historical returns that prove nothing about forward performance. The real tension: NuScale (SMR) has regulatory approval but faces massive capex per MW and customer concentration risk; Oklo (OKLO) has an attractive recurring-revenue model but zero operating plants and execution risk across manufacturing, siting, and fuel supply. Neither comparison addresses the elephant: both companies need sustained AI/data-center demand to justify valuations, and that demand is cyclical. The article doesn't quantify unit economics, capex requirements, or timeline to profitability for either.
If AI power demand proves as durable as proponents claim, the first-mover with regulatory approval (NuScale) could capture market share before Oklo scales, making timing and regulatory certainty worth more than a theoretically superior business model that hasn't been proven at scale.
"Both stocks remain speculative pre-commercial bets whose timelines the article downplays in favor of promotional messaging."
The article frames NuScale's regulatory lead against Oklo's recurring-revenue ownership model, yet both face identical near-term hurdles: multi-year NRC licensing timelines, massive capex needs, and uncertain power-purchase agreements from hyperscalers. NuScale's first-of-a-kind plant cost overruns already signal execution risk, while Oklo remains pre-revenue with unproven fuel recycling claims. The Motley Fool framing serves mainly to steer readers toward its paid service rather than providing concrete valuation anchors such as forward multiples or deployment milestones post-2026.
NuScale could secure the first commercial SMR deployment in the US by 2029-2030 if the NRC fast-tracks its follow-on modules, delivering revenue years ahead of Oklo and justifying a re-rating regardless of current cost issues.
"Both companies are currently priced for perfection in a sector where regulatory, technical, and capital-expenditure risks are historically catastrophic for early-stage investors."
The article frames this as a binary choice between NuScale (SMR) and Oklo (OKLO), but both are essentially pre-revenue speculative plays disguised as infrastructure plays. SMR holds a regulatory advantage with its NRC design certification, yet its unit economics remain unproven at scale, facing significant cost-overrun risks typical of first-of-a-kind nuclear projects. OKLO’s 'power-as-a-service' model is intellectually appealing but faces a brutal path to commercialization and fuel supply chain hurdles that the article ignores. Investors are currently pricing in a 'nuclear renaissance' that assumes perfect execution, ignoring the reality that these companies are years away from meaningful EBITDA, let alone positive free cash flow. This is a high-beta bet on policy tailwinds, not fundamental value.
If the U.S. government aggressively subsidizes Small Modular Reactors (SMRs) to meet data center energy demands, the first-mover advantage for NuScale could create a 'moat' that makes current valuations look like a bargain in hindsight.
"Near-term stock upside depends more on actual pilots and financing commitments than on regulatory timing alone."
NuScale’s regulatory head start is real, but deployment economics remain opaque: capex-heavy SMRs face long lead times, financing hurdles, and grid integration uncertainties. Oklo’s ‘ownership model’ could unlock decades of revenue only if utilities adopt a novel financing/ownership structure and secure repeat pilots; otherwise the stock is pre-revenue risk. The article omits policy dynamics (IRA subsidies, carbon pricing), supply-chain risks, and potential delays in NRC approvals for next-gen small reactors. In the near term, the upside hinges on concrete pilots and stabilized pricing, not just a regulatory handicap being overcome.
The strongest counterpoint is that NuScale’s head start may never translate into timely cash flow if pilots slip or utilities balk at SMR economics, while Oklo’s revenue moat hinges on unproven financing models that could collapse in a tougher credit environment.
"Oklo's revenue moat inverts into a cash-flow trap if refinancing costs rise before plants achieve scale."
ChatGPT flags financing collapse risk in a tougher credit environment—that's the overlooked bear case. Both panelists assume IRA subsidies and utility capex appetite persist, but if rates stay elevated or recession hits, Oklo's recurring-revenue model becomes a liability: long-term contracts lock in low margins while capex demands spike. NuScale at least has fixed-price contracts with utilities already signed. The article doesn't address credit-cycle timing at all.
"NuScale's fixed-price contracts are not a reliable buffer against credit risks due to existing project overruns and potential renegotiations."
Claude overstates NuScale's contract stability. The fixed-price deals cited are limited to the initial UAMPS project, which has already seen delays and cost escalations beyond original estimates. In a high-rate environment, utilities could renegotiate or walk away from follow-on modules, exposing NuScale to the same capex volatility Oklo faces. This undercuts the claim that NuScale is insulated from credit cycles while Oklo is not.
"HALEU fuel supply constraints represent a more immediate, existential threat to both companies than either credit cycles or regulatory timelines."
Grok and Claude are missing the critical bottleneck: HALEU fuel availability. Both companies are essentially captive to the Department of Energy’s supply chain for High-Assay Low-Enriched Uranium. Regardless of NRC approvals or financing models, if the domestic fuel supply remains constrained, both firms face a hard ceiling on deployment. NuScale’s design is more fuel-intensive, while Oklo’s recycling proposition is regulatory vaporware until the NRC proves otherwise. The real risk isn't just credit; it's fuel scarcity.
"Fuel supply constraints (HALEU) could cap deployment for NuScale and Oklo, making near-term revenue visibility and valuations vulnerable despite subsidies and contracts."
Gemini’s HALEU bottleneck framing is right to flag a supply-chain choke, but it’s likely to be the binding constraint, not a secondary risk. If DOE can ramp, fuel availability could still cap deployments for NuScale and Oklo, regardless of IRA subsidies or contracts. The broader point: even with subsidies, a fuel-supply cliff could force a near-term stall in revenue visibility and push valuation risk higher than discussed. (speculative)
The panel consensus is bearish on NuScale (SMR) and Oklo (OKLO), citing significant risks including regulatory hurdles, execution challenges, uncertain power-purchase agreements, and potential fuel scarcity. Both companies are seen as speculative plays with uncertain unit economics and deployment timelines.
No significant opportunities were highlighted by the panel.
Fuel scarcity, specifically the availability of High-Assay Low-Enriched Uranium (HALEU), is identified as the single biggest risk by Gemini, with a confidence of 0.85.